Table 1.
ACh | ||||
---|---|---|---|---|
Conditions | PGF2α (mN mm−1) | pD2 | Emax | n |
1 | ||||
Endothelium (+) | 0.74 ± 0.13 | 8.6 ± 0.1 | 93.1 ± 3.7 | 7 |
Endothelium (−) | 0.81 ± 0.15 | N.D | 2.8 ± 6.4*** | 7 |
2 | ||||
None | 0.88 ± 0.10 | 8.6 ± 0.1 | 96.3 ± 1.4 | 7 |
l -NNA | 1.09 ± 0.15 | 8.1 ± 0.1*** | 88.7 ± 3.4 | 7 |
l -NNA + diclofenac | 1.07 ± 0.15 | 7.9 ± 0.1*** | 90.7 ± 3.9 | 7 |
3 | ||||
None | 0.76 ± 0.21 | 8.9 ± 0.1 | 92.3 ± 5.1 | 7 |
l -NNA + diclofenac | 0.80 ± 0.17 | 7.5 ± 0.3* | 87.2 ± 2.7 | 7 |
l -NNA + diclofenac + apamin + charybdotoxin | 1.22 ± 0.32† | N.D. | −7.9 ± 17.5**†† | 7 |
4 | ||||
l -NNA + diclofenac | 0.99 ± 0.10 | 7.3 ± 0.1 | 81.8 ± 0.04 | 7 |
l -NNA + diclofenac + apamin + TRAM 34 | 1.13 ± 0.13 | 6.6 ± 0.2† | 62.9 ± 0.05†† | 7 |
l -NNA + diclofenac + apamin + TRAM 34 + margatoxin | 1.22 ± 0.22 | 6.6 ± 0.2† | 33.0 ± 0.09†††# | 7 |
The concentration of PGF2α was 3 µM in endothelium-intact strips not treated with l -NNA but 1 µM in endothelium-intact strips treated with l -NNA and in endothelium-denuded preparations. *, **, ***P < 0.05, 0.01, 0.001 vs. ‘Endothelium (+)’ or ‘None’. †, ††, †††P < 0.05, 0.01, 0.001 vs. ‘l -NNA + diclofenac’. #P < 0.05 vs. ‘l -NNA + diclofenac + apamin + TRAM 34’.